ALLR
Allarity Therapeutics, Inc.
+0.04 (+3.90%)1.20USD143K成交股數19.1M市值0.0本益比(近四季)55.3股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0 | 25K | – | 0 | 0 | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.3M | 1.3M | 1.2M | 2.3M | 1.4M | 1.8M | 1.0M | 1.1M | 2.2M | 1.9M | 1.1M | 1.4M |
| 銷售管理費用 | 1.3M | 1.4M | 1.3M | 1.8M | 1.6M | 5.5M | 1.6M | 2.3M | 2.1M | 2.5M | 3.1M | 2.2M |
| 營業利益 | −2.7M-12% | −2.7M-63% | −2.5M-80% | −4.1M+23% | −3.0M-28% | −7.3M+65% | −12.3M+196% | −3.4M-8% | −4.2M | −4.4M | −4.2M | −3.7M |
| 營業利益率 | – | -10,752.0% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.4M+25% | −2.8M-63% | −2.8M-76% | −2.3M+42% | −2.7M-29% | −7.5M+68% | −11.6M+387% | −1.6M-51% | −3.8M | −4.4M | −2.4M | −3.4M |
| 淨利率 | – | -11,000.0% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | -0.11-100% | -22.14 | -2.03 | -525.53 | -6356.06 |
| 稀釋股數 | – | – | – | – | – | – | – | 15.0M | 175K | 2.5M | 18.6K | 528 |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 17.0M | 19.8M | 16.9M | 17.8M | 25.2M | 19.5M | 18.5M | 19.2M | 312K | 1.4M | 420K | 295K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 32.1M | 34.9M | 20.8M | 21.2M | 29.7M | 22.7M | 20.4M | 30.9M | 12.0M | 13.9M | 13.4M | 12.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | 2.7M | – | – |
| 總負債 | 28.6M | 28.0M | 8.8M | 9.0M | 11.1M | 10.8M | 7.4M | 11.0M | 18.4M | 17.3M | 14.1M | 13.0M |
| 股東權益 | 3.5M | 6.9M | 12.0M | 12.2M | 18.7M | 11.8M | 13.0M | 19.8M | −6.5M | −3.4M | −723K | −3.1M |
| 負債比 | 89.0% | 80.2% | 42.2% | 42.6% | 37.2% | 47.9% | 36.4% | 35.8% | 154.1% | 124.4% | 105.4% | 102.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | −1.3M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.5M | – | – | −2.7M+92% | – | – | – | −1.4M | – | – | −3.2M |
| 資本支出 | – | 64K | – | – | 0 | – | – | – | – | – | – | – |
| 自由現金流 | – | −4.6M | – | – | −2.7M | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | 11K | – | – | – | 2K | – | – | 10K |
| 買回庫藏股 | – | 262K | – | – | 0 | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -18,228.0% | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 320K
| License | 320K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 320K | – | −11.2M | -3,509.7% | – | −14.8M |
| FY2024 | 0 | – | −24.5M | –% | – | −17.7M |
| FY2023 | – | – | −11.9M | –% | -10.26 | −12.7M |
| FY2022 | – | – | −16.1M | –% | -3093.42 | −16.8M |
| FY2021 | −1.3M | – | −26.6M | 1,978.3% | -4.19 | – |
| FY2020 | – | – | −6.6M | –% | – | −7.3M |